NCT00637793View on ClinicalTrials.gov

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2008

Study Completion Date

November 30, 2008

Conditions
XerostomiaSjogren's Syndrome
Interventions
DRUG

NGX267

2 capsules in the am of each treatment period

DRUG

NGX267

2 capsules in the am of each treatment period

DRUG

NGX267

2 capsules in the am of each treatment period

DRUG

NGX267

2 capsules in the am of each treatment period

Trial Locations (3)

16635

Altoona Center for Clinical Research, Duncansville

19104

Penn Rheumatology Associates and Sjogren's Syndrome Center, Philadelphia

78705

Walter F. Chase MD PA, Austin

Sponsors
All Listed Sponsors
lead

TorreyPines Therapeutics

INDUSTRY

NCT00637793 - Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome | Biotech Hunter | Biotech Hunter